That the T2D‐risk ZnT8 R325 variant is the more active form of the transporter suggests that people with the R325 variant may have an increased zinc content in their insulin granules as indicated by the data on human islets 41. This evidence concerns the gene SLC30A10 and type 2 diabetes mellitus.